These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 6938012

  • 1. Cardiovascular complications to treatment of prostate cancer with estramustine phosphate (Estracyt) or conventional estrogen. A follow-up of 212 randomized patients.
    Hedlund PO, Gustafson H, Sjögren S.
    Scand J Urol Nephrol Suppl; 1980; 55():103-5. PubMed ID: 6938012
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter study.
    Lundgren R, Sundin T, Colleen S, Lindstedt E, Wadström L, Carlsson S, Hellsten S, Pompeius R, Holmquist B, Nilsson T.
    Scand J Urol Nephrol; 1986; 20(2):101-5. PubMed ID: 3529368
    [Abstract] [Full Text] [Related]

  • 3. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ, Morales A.
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [Abstract] [Full Text] [Related]

  • 4. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
    Kalland T, Haukaas S.
    Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
    [Abstract] [Full Text] [Related]

  • 5. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K.
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC, Fosså SD, Kaalhus O.
    Tidsskr Nor Laegeforen; 1984 Oct 10; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical study of estramustine phosphate (Estracyt) on prostatic cancer].
    Murase T, Mitsuya H, Honda N, Fukatu H, Aota Y, Shinoda M, Yoshida K, Sobajima T, Ohishi M, Tsumura Y.
    Hinyokika Kiyo; 1989 Jan 10; 35(1):179-85. PubMed ID: 2729015
    [Abstract] [Full Text] [Related]

  • 8. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H, Imai K, Suzuki T, Yuasa H, Takahashi E.
    Gan To Kagaku Ryoho; 1984 Oct 10; 11(10):2106-14. PubMed ID: 6486830
    [Abstract] [Full Text] [Related]

  • 9. [The phase IV studies with Estracyt in prostatic cancer--supplementary report: results of long-term therapy].
    Ohhori T, Kubo T, Kawamura S, Suzuki T, Yagihashi Y, Kudo T, Tsuchida S, Harada T, Sasaki S, Orikasa S.
    Hinyokika Kiyo; 1992 Aug 10; 38(8):979-87. PubMed ID: 1414749
    [Abstract] [Full Text] [Related]

  • 10. [Value of estramustine phosphate in the treatment of estrogen-resistant prostatic adenocarcinoma].
    Toulouse J, Jung JL, Bittard M.
    J Urol (Paris); 1984 Aug 10; 90(1):27-33. PubMed ID: 6725973
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA, Chantada Abal V, Lamas Meilan AC, González Martín M.
    Actas Urol Esp; 1984 Aug 10; 8(5):399-402. PubMed ID: 6524487
    [No Abstract] [Full Text] [Related]

  • 12. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L, Berlin T, Boman J, Collste L, Edsmyr F, Esposti PL, Gustafsson H, Hedlund PO, Hultgren L, Leander G, Nordle O, Norlén H, Tillegård P.
    Scand J Urol Nephrol Suppl; 1980 Aug 10; 55():143-5. PubMed ID: 6259722
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU.
    Ugeskr Laeger; 1985 Oct 14; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Experiences with estramustinphosphate (Estracyt) in estrogen-resistant metastasizing prostatic cancer].
    Köller A, Lunglmayr G.
    Wien Med Wochenschr; 1983 Oct 14; 133(7):179-81. PubMed ID: 6868629
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.